Here, we sought to determine if the serum metabolome could identify MS individuals exhibiting high 11C-PK11195 TSPO binding and, by extension, predict disease progression similarly to 11C-PK11195 TSPO binding. The gene discussed is TSPO; the disease is myeloid sarcoma.